23ANDME HOLDING CO -CLASS A (ME) Stock Fundamental Analysis

NASDAQ:ME • US90138Q3065

0.6063 USD
-0.16 (-21.26%)
At close: Mar 28, 2025
0.5 USD
-0.11 (-17.53%)
After Hours: 3/28/2025, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall ME gets a fundamental rating of 2 out of 10. We evaluated ME against 102 industry peers in the Health Care Providers & Services industry. ME scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ME does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year ME has reported negative net income.
  • ME had a negative operating cash flow in the past year.
  • ME had negative earnings in each of the past 5 years.
  • In the past 5 years ME always reported negative operating cash flow.
ME Yearly Net Income VS EBIT VS OCF VS FCFME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -200M -400M -600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -138.01%, ME is doing worse than 93.64% of the companies in the same industry.
  • ME has a worse Return On Equity (-545.25%) than 86.36% of its industry peers.
Industry RankSector Rank
ROA -138.01%
ROE -545.25%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ME Yearly ROA, ROE, ROICME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • With a decent Gross Margin value of 52.58%, ME is doing good in the industry, outperforming 78.18% of the companies in the same industry.
  • ME's Gross Margin has been stable in the last couple of years.
  • ME does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5Y0.67%
ME Yearly Profit, Operating, Gross MarginsME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • ME does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for ME. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ME Yearly Shares OutstandingME Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 100M 200M 300M 400M
ME Yearly Total Debt VS Total AssetsME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

  • ME has an Altman-Z score of -13.45. This is a bad value and indicates that ME is not financially healthy and even has some risk of bankruptcy.
  • ME has a worse Altman-Z score (-13.45) than 90.91% of its industry peers.
  • ME has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -13.45
ROIC/WACCN/A
WACC8.71%
ME Yearly LT Debt VS Equity VS FCFME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.11 indicates that ME should not have too much problems paying its short term obligations.
  • The Current ratio of ME (1.11) is worse than 68.18% of its industry peers.
  • A Quick Ratio of 0.96 indicates that ME may have some problems paying its short term obligations.
  • ME has a Quick ratio of 0.96. This is in the lower half of the industry: ME underperforms 69.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.96
ME Yearly Current Assets VS Current LiabilitesME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for ME have decreased strongly by -29.41% in the last year.
  • The Revenue for ME has decreased by -15.83% in the past year. This is quite bad
  • Measured over the past years, ME shows a very negative growth in Revenue. The Revenue has been decreasing by -13.01% on average per year.
EPS 1Y (TTM)-29.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-197.53%
Revenue 1Y (TTM)-15.83%
Revenue growth 3Y-3.43%
Revenue growth 5Y-13.01%
Sales Q2Q%34.67%

3.2 Future

  • ME is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.35% yearly.
  • ME is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.08% yearly.
EPS Next Y-329.17%
EPS Next 2Y-99.49%
EPS Next 3Y25.35%
EPS Next 5YN/A
Revenue Next Year22.44%
Revenue Next 2Y19.85%
Revenue Next 3Y5.77%
Revenue Next 5Y19.08%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ME Yearly Revenue VS EstimatesME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
ME Yearly EPS VS EstimatesME Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -10 -20 -30 -40 -50

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • ME reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ME is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ME Price Earnings VS Forward Price EarningsME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ME Per share dataME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ME's earnings are expected to grow with 25.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-99.49%
EPS Next 3Y25.35%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

23ANDME HOLDING CO -CLASS A

NASDAQ:ME (3/28/2025, 8:00:00 PM)

After market: 0.5 -0.11 (-17.53%)

0.6063

-0.16 (-21.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)N/A
Inst Owners24.69%
Inst Owner Change-80.3%
Ins Owners9.89%
Ins Owner Change0%
Market Cap16.27M
Revenue(TTM)208.78M
Net Income(TTM)-382.87M
Analysts37.78
Price Target2.12 (249.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.94%
Min Revenue beat(2)-5.66%
Max Revenue beat(2)1.78%
Revenue beat(4)2
Avg Revenue beat(4)-4.8%
Min Revenue beat(4)-24.62%
Max Revenue beat(4)9.3%
Revenue beat(8)4
Avg Revenue beat(8)-6%
Revenue beat(12)6
Avg Revenue beat(12)-3.09%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-94.8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF N/A
P/OCF N/A
P/B 0.23
P/tB 0.73
EV/EBITDA N/A
EPS(TTM)-13.2
EYN/A
EPS(NY)-52.53
Fwd EYN/A
FCF(TTM)-6.05
FCFYN/A
OCF(TTM)-5.76
OCFYN/A
SpS7.78
BVpS2.62
TBVpS0.83
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -138.01%
ROE -545.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.58%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5Y0.67%
F-Score4
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 32.25%
Cap/Sales 3.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 0.96
Altman-Z -13.45
F-Score4
WACC8.71%
ROIC/WACCN/A
Cap/Depr(3y)39.05%
Cap/Depr(5y)93.91%
Cap/Sales(3y)4.44%
Cap/Sales(5y)8.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-197.53%
EPS Next Y-329.17%
EPS Next 2Y-99.49%
EPS Next 3Y25.35%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.83%
Revenue growth 3Y-3.43%
Revenue growth 5Y-13.01%
Sales Q2Q%34.67%
Revenue Next Year22.44%
Revenue Next 2Y19.85%
Revenue Next 3Y5.77%
Revenue Next 5Y19.08%
EBIT growth 1Y37.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.46%
EBIT Next 3Y21.64%
EBIT Next 5YN/A
FCF growth 1Y2.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.64%
OCF growth 3YN/A
OCF growth 5YN/A

23ANDME HOLDING CO -CLASS A / ME FAQ

Can you provide the ChartMill fundamental rating for 23ANDME HOLDING CO -CLASS A?

ChartMill assigns a fundamental rating of 2 / 10 to ME.


Can you provide the valuation status for 23ANDME HOLDING CO -CLASS A?

ChartMill assigns a valuation rating of 1 / 10 to 23ANDME HOLDING CO -CLASS A (ME). This can be considered as Overvalued.


Can you provide the profitability details for 23ANDME HOLDING CO -CLASS A?

23ANDME HOLDING CO -CLASS A (ME) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for ME stock?

The Earnings per Share (EPS) of 23ANDME HOLDING CO -CLASS A (ME) is expected to decline by -329.17% in the next year.